Rayna Herman

Rayna Herman currently serves as Chief Commercial Officer at Shorla Oncology and is a member of the Board of Advisors at Almaden Genomics. Prior to these roles, Rayna held the position of Chief Commercial Officer at EVERSANA, where responsibilities included developing strategies for biopharmaceutical product launches and managing P&L across Rare, Oncology, and Neuroscience products. Additionally, Rayna served as Senior Vice President, Commercial at EVERSANA after the acquisition of Health Strategies Group, where commercial solutions were developed for clients in the biopharma, diagnostics, and medical device sectors. As Principal and Senior Vice President of Sales and Marketing at Health Strategies Group, Rayna played a pivotal role in transforming the company and leading its sale to private equity. Rayna's early career included various sales and marketing roles at Merck. Educational qualifications include an MBA from Washington University in St. Louis and a BA in Chemistry from Indiana University Bloomington.